MSB 4.69% $1.45 mesoblast limited

invitation to madamanswer to comment, page-37

  1. 16,938 Posts.
    lightbulb Created with Sketch. 8400
    "I had expected in response several lines that would focus on the trial itself and potential ramifications. Instead madam went into autopilot and repeated ALL his accounting/financial and negative commentary."

    @dingle,

    Here's my response to your thread-starting post:

    https://hotcopper.com.au/threads/in....3342096/page-6?post_id=23865147#.WOWsOG996Uk

    Can you point out a single reference therein which is of an accounting/financial construct?

    Besides, what did you expect from me?
    A ground-breaking treatise on the physiological bio-molecular mechanisms behind mesenchymal stem cells?

    It really is quite astonishing: you pose a question on subject matter to someone who readily concedes to not being the most proficient at said subject, and then you criticise that person's answer for not being up to scratch.

    That's a bit like asking a plumber a question about heart surgery and then criticising him for not knowing how to conduct a triple bypass operation.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.